Asta Biochemicals Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 15-11-2024
- Paid Up Capital ₹ 0.10 M
as on 15-11-2024
- Company Age 14 Year, 25 Days
- Last Filing with ROC 31 Mar 2023
- Revenue 79.66%
(FY 2023)
- Profit 179.58%
(FY 2023)
- Ebitda -232.71%
(FY 2023)
- Net Worth 30.21%
(FY 2023)
- Total Assets 144.00%
(FY 2023)
About Asta Biochemicals
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Dilip Kumar, Kenchappa Raghavendra, Hemmaragala Swamy, and One other member serve as directors at the Company.
- CIN/LLPIN
U24110KA2010PTC056337
- Company No.
056337
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Dec 2010
- Date of AGM
30 Dec 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Asta Biochemicals Private Limited offer?
Asta Biochemicals Private Limited offers a wide range of products and services, including Soaps, Detergent Powder & Cakes, Soap Raw Material, Essential & Aromatic Oils, Seeds Oil and Fruit Oils, Food Emulsifiers, Soya Lecithin, Cosmetics, Hair & Beauty Products, Cosmetic Raw Material, Olive Oil, Blended Olive Oil.
Who are the key members and board of directors at Asta Biochemicals?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Dilip Kumar  | Director | 21-Dec-2012 | Current |
| Kenchappa Raghavendra | Director | 21-Dec-2012 | Current |
| Hemmaragala Swamy | Director | 27-Jan-2021 | Current |
| Munna Lal | Director | 27-Jan-2021 | Current |
Financial Performance of Asta Biochemicals.
Asta Biochemicals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 79.66% increase. The company also saw a substantial improvement in profitability, with a 179.58% increase in profit. The company's net worth Soared by an impressive increase of 30.21%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Asta Biochemicals?
In 2023, Asta Biochemicals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Asta Biochemicals?
Asta Biochemicals has a workforce of 10 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Asta Biochemicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Asta Biochemicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
